Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

NCT02455622 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Hunter Syndrome

Interventions

DRUG: Elaprase for intravenous (IV) infusion

Sponsor

Shire

Collaborators

[object Object]